About Bioklone
Bioklone is a company based in Chennai (India) founded in 2006 by T Venkataramani and Rajeshwari Krishnamurthy. Bioklone operates in a competitive market with competitors including Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
- Headquarter Chennai, India
- Founders T Venkataramani, Rajeshwari Krishnamurthy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioklone Biotech Private Limited
- Date of Incorporation 12 Mar, 2013
- Jurisdiction Chennai, Tamil Nadu, India
-
Annual Revenue
$94.66 K (USD)36.8as on Mar 31, 2023
-
Net Profit
-$10.33 K (USD)52.12as on Mar 31, 2023
-
EBITDA
$11.14 K (USD)180.02as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Bioklone
Detailed funding history for Bioklone
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioklone
Investment portfolio details for Bioklone
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bioklone
Detailed financials for Bioklone
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioklone Comparisons
Peer comparison for Bioklone
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioklone
Bioklone operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Laboratory testing and contract research services are provided globally.
|
|
| Locked | Locked | Locked |
Provider of CRO and CDMO services
|
|
| Locked | Locked | Locked |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| Locked | Locked | Locked |
Branded pharmaceutical products are developed, marketed, and distributed globally.
|
|
| Locked | Locked | Locked |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| Locked | Locked | Locked |
CRO focused on clinical development for phases II & III clinical trials and regulatory affair services
|
Detailed competitors of Bioklone
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioklone
Complete news archive for Bioklone
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioklone
Bioklone was founded in 2006.
Bioklone is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Annual revenue of Bioklone is $94.66K as on Mar 31, 2023.
Bioklone Biotech Private Limited is a bioservice provider that specializes in the development of customized antibodies and assays for research, diagnostic, and pharmaceutical applications. The company uses a range of techniques, including polyclonal antibody development, assay development, and cell viability and proliferation assays, to support various industries. With a focus on customized solutions, Bioklone works with clients to develop antibodies and assays that meet their specific needs.
Bioklone's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.